Zoll Medical said today that it inked a deal to acquire Cardiac Science Corp., and its portfolio of automated external defibrillators.
Deerfield, Wis.-based Cardiac Science operates in North America, Europe and Asia. The company has installed more than 500,000 units in nearly 100 countries, according to Zoll.
The two companies did not disclose financial terms of the agreement.
“We are excited about the alignment of our two companies and our combined ability to put life-saving technology in the hands of more lay rescuers and first responders answering medical emergencies,” Elijah White, president of Zoll Resuscitation, said in prepared remarks.
“Zoll and Cardiac Science have been delivering AED solutions for the better part of two decades. As we look to the future together, our combined organization will provide more choices to current and future customers. This includes continuing to actively promote, market, and supply the Powerheart line of AEDs and Rescue Ready services in addition to our Zoll AEDs and PlusTrac program management. Moving forward, Zoll plans to continue ongoing development and to introduce new products for both Powerheart and Zoll brands,” White added.
“Joining Zoll is the right opportunity for our business, our people, and our customers,” Dev Kurdikar, president & CEO of Cardiac Science, said. “We are enthusiastic that our combined portfolios will be able to address a greater range of needs for our customers and look forward to accelerated innovation to meet persistent needs in the community for these vital emergency services. By expanding the reach of our current and future line of Powerheart AEDs, we will be able to further fulfill our mission of saving lives.”